Marathon Capital Management’s PHYSICIANS REALTY TRUST DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-455,584
Closed -$6.06M 166
2023
Q4
$6.06M Sell
455,584
-7,611
-2% -$90.4K 1.52% 16
2023
Q3
$5.65M Sell
463,195
-2,571
-0.6% -$35.5K 1.42% 18
2023
Q2
$6.52M Sell
465,766
-5,171
-1% -$73.5K 1.61% 13
2023
Q1
$7.03M Buy
470,937
+393
+0.1% +$5.93K 1.73% 10
2022
Q4
$6.81M Sell
470,544
-14,475
-3% -$210K 1.88% 8
2022
Q3
$7.29M Buy
485,019
+379,789
+361% +$6.41M 2.08% 5
2022
Q2
$1.84M Buy
105,230
+2,645
+3% +$46.7K 0.59% 40
2022
Q1
$1.8M Buy
102,585
+20,375
+25% +$358K 0.52% 46
2021
Q4
$1.55M Sell
82,210
-7,225
-8% -$133K 0.36% 50
2021
Q3
$1.58M Sell
89,435
-50
-0.1% -$925 0.36% 53
2021
Q2
$1.65M Sell
89,485
-1,000
-1% -$18.6K 0.38% 50
2021
Q1
$1.6M Buy
90,485
+2,145
+2% +$38.1K 0.42% 45
2020
Q4
$1.57M Sell
88,340
-3,450
-4% -$61.8K 0.46% 44
2020
Q3
$1.64M Sell
91,790
-1,735
-2% -$30.9K 0.6% 36
2020
Q2
$1.64M Buy
+93,525
New +$1.53M 0.63% 28

Other funds holding DOC

Marathon Capital Management's DOC Position: Q1 2024 in Review

Marathon Capital Management sold out of PHYSICIANS REALTY TRUST (DOC) in Q1 2024, closing a stake of 455,584 shares — an estimated $6.06M sold.

Marathon Capital Management first reported a position in DOC in Q2 2020 and held it in 15 quarters. The position peaked at $7.29M in Q3 2022. 9 funds tracked by Wall St. Rank hold DOC as of Q1 2024.

  • Marathon Capital Management reported no remaining PHYSICIANS REALTY TRUST position as of Q1 2024 after selling out during the quarter.
  • Marathon Capital Management sold 455,584 PHYSICIANS REALTY TRUST shares in Q1 2024, an estimated $6.06M.
  • Marathon Capital Management first reported a position in PHYSICIANS REALTY TRUST in Q2 2020 and held it in 15 quarters.
  • Marathon Capital Management's PHYSICIANS REALTY TRUST position peaked at $7.29M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held PHYSICIANS REALTY TRUST as of Q1 2024.

Based on Marathon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.